Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

The research adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes. | ITV National News ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...